Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22677155

Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2012 Jul
First author
Wang M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2012 Jul;13(7):657-8. doi: 10.1016/S1470-2045(12)70223-1.
    note
    Source null
    related pmid
    22677153
    relationship
    Comment in

Authors and identifiers

  1. name
    Wang M
    type
    Author
  2. name
    Fayad L
    type
    Author
  3. name
    Wagner-Bartak N
    type
    Author
  4. name
    Zhang L
    type
    Author
  5. name
    Hagemeister F
    type
    Author
  6. name
    Neelapu SS
    type
    Author
  7. name
    Samaniego F
    type
    Author
  8. name
    McLaughlin P
    type
    Author
  9. name
    Fanale M
    type
    Author
  10. name
    Younes A
    type
    Author
  11. name
    Cabanillas F
    type
    Author
  12. name
    Fowler N
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Wang M
    type
    Author
  2. name
    Fayad L
    type
    Author
  3. name
    Wagner-Bartak N
    type
    Author
  4. name
    Zhang L
    type
    Author
  5. name
    Hagemeister F
    type
    Author
  6. name
    Neelapu SS
    type
    Author
  7. name
    Samaniego F
    type
    Author
  8. name
    McLaughlin P
    type
    Author
  9. name
    Fanale M
    type
    Author
  10. name
    Younes A
    type
    Author
  11. name
    Cabanillas F
    type
    Author
  12. name
    Fowler N
    type
    Author
bibliography ids
  1. nci-bib-6c37ca04a3d9f00e928dce86
book metadata
content sha256
3ff42add620fac2fc91062508dc5675390d4b1c52ca183695b8384b0bea84cf4
document type
citation
dois
  1. 10.1016/S1470-2045(12)70200-0
electronic publication date
display
2012 Jun 6
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:22677155
immutable id
pubmed:22677155@3ff42add620fac2fc91062508dc5675390d4b1c52ca183695b8384b0bea84cf4
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
7
name
The Lancet. Oncology
nlm unique id
100957246
pages
716-23
volume
13
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2012 Jul;13(7):657-8. doi: 10.1016/S1470-2045(12)70223-1.
    note
    Source null
    related pmid
    22677153
    relationship
    Comment in
outcomes validated
false
pmid
22677155
provenance
batch id
c95be1d0b8cf19942816
provider
NCBI PubMed ESummary
record sha256
a6fafc34697af25763da9b3d545e13aeb7b9bfd950fdf8b8e1eaf7bb800075ee
response sha256
a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
retrieved at
2026-09-09T23:46:47.691937+00:00
publication date
display
2012 Jul
precision
month
year
2012
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22677155/
title
Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial.

Preserved source evidence · Not medical advice